Skip to main content
. Author manuscript; available in PMC: 2012 Apr 24.
Published in final edited form as: AIDS. 2011 Apr 24;25(7):919–928. doi: 10.1097/QAD.0b013e328345889d

Fig. 1. Longitudinal characterisitics of peripheral neuropathy and combination antiretroviral therapy initiation.

Fig. 1

(a) Peripheral neuropathy over time. (b) Neuropathic signs over time. (c) Neuropathic symptoms over time. (d) Antiretroviral therapy (ART) use over time. d4t, stavudine; ddc, zalcitabine; ddi, didanosine; nART, neurotoxic antiretroviral therapy.